K W Yeom1, R M Lober2, A Alexander2, S H Cheshier3, M S B Edwards3. 1. From the Departments of Radiology (K.W.Y.) kyeom@stanford.edu. 2. Neurosurgery (R.M.L., A.A., S.H.C., M.S.B.E.). 3. Neurosurgery (R.M.L., A.A., S.H.C., M.S.B.E.)Division of Pediatric Neurosurgery (S.H.C., M.S.B.E.), Lucile Packard Children's Hospital at Stanford University, Palo Alto, California.
Abstract
BACKGROUND AND PURPOSE: Reduced cerebral perfusion has been observed with elevated intracranial pressure. We hypothesized that arterial spin-labeled CBF can be used as a marker for symptomatic hydrocephalus. MATERIALS AND METHODS: We compared baseline arterial spin-labeled CBF in 19 children (median age, 6.5 years; range, 1-17 years) with new posterior fossa brain tumors and clinical signs of intracranial hypertension with arterial spin-labeled CBF in 16 age-matched controls and 4 patients with posterior fossa tumors without ventriculomegaly or signs of intracranial hypertension. Measurements were recorded in the cerebrum at the vertex, deep gray nuclei, and periventricular white matter and were assessed for a relationship to ventricular size. In 16 symptomatic patients, we compared cerebral perfusion before and after alleviation of hydrocephalus. RESULTS: Patients with uncompensated hydrocephalus had lower arterial spin-labeled CBF than healthy controls for all brain regions interrogated (P < .001). No perfusion difference was seen between asymptomatic patients with posterior fossa tumors and healthy controls (P = 1.000). The median arterial spin-labeled CBF increased after alleviation of obstructive hydrocephalus (P < .002). The distance between the frontal horns inversely correlated with arterial spin-labeled CBF of the cerebrum (P = .036) but not the putamen (P = .156), thalamus (P = .111), or periventricular white matter (P = .121). CONCLUSIONS: Arterial spin-labeled-CBF was reduced in children with uncompensated hydrocephalus and restored after its alleviation. Arterial spin-labeled-CBF perfusion MR imaging may serve a future role in the neurosurgical evaluation of hydrocephalus, as a potential noninvasive method to follow changes of intracranial pressure with time.
BACKGROUND AND PURPOSE: Reduced cerebral perfusion has been observed with elevated intracranial pressure. We hypothesized that arterial spin-labeled CBF can be used as a marker for symptomatic hydrocephalus. MATERIALS AND METHODS: We compared baseline arterial spin-labeled CBF in 19 children (median age, 6.5 years; range, 1-17 years) with new posterior fossa brain tumors and clinical signs of intracranial hypertension with arterial spin-labeled CBF in 16 age-matched controls and 4 patients with posterior fossa tumors without ventriculomegaly or signs of intracranial hypertension. Measurements were recorded in the cerebrum at the vertex, deep gray nuclei, and periventricular white matter and were assessed for a relationship to ventricular size. In 16 symptomatic patients, we compared cerebral perfusion before and after alleviation of hydrocephalus. RESULTS:Patients with uncompensated hydrocephalus had lower arterial spin-labeled CBF than healthy controls for all brain regions interrogated (P < .001). No perfusion difference was seen between asymptomatic patients with posterior fossa tumors and healthy controls (P = 1.000). The median arterial spin-labeled CBF increased after alleviation of obstructive hydrocephalus (P < .002). The distance between the frontal horns inversely correlated with arterial spin-labeled CBF of the cerebrum (P = .036) but not the putamen (P = .156), thalamus (P = .111), or periventricular white matter (P = .121). CONCLUSIONS: Arterial spin-labeled-CBF was reduced in children with uncompensated hydrocephalus and restored after its alleviation. Arterial spin-labeled-CBF perfusion MR imaging may serve a future role in the neurosurgical evaluation of hydrocephalus, as a potential noninvasive method to follow changes of intracranial pressure with time.
Authors: M Preuss; K-T Hoffmann; M Reiss-Zimmermann; W Hirsch; A Merkenschlager; J Meixensberger; M Dengl Journal: Childs Nerv Syst Date: 2013-07-07 Impact factor: 1.475
Authors: F Q Ye; K F Berman; T Ellmore; G Esposito; J D van Horn; Y Yang; J Duyn; A M Smith; J A Frank; D R Weinberger; A C McLaughlin Journal: Magn Reson Med Date: 2000-09 Impact factor: 4.668
Authors: Tamara D Simon; Jay Riva-Cambrin; Raj Srivastava; Susan L Bratton; J Michael Dean; John R W Kestle Journal: J Neurosurg Pediatr Date: 2008-02 Impact factor: 2.375
Authors: Paul H Leliefeld; Rob H J M Gooskens; Koen L Vincken; Lino M P Ramos; Jeroen van der Grond; Cees A F Tulleken; L Jaap Kappelle; Patrick W Hanlo Journal: J Neurosurg Pediatr Date: 2008-09 Impact factor: 2.375
Authors: Anders Eklund; Peter Smielewski; Iain Chambers; Noam Alperin; Jan Malm; Marek Czosnyka; Anthony Marmarou Journal: Med Biol Eng Comput Date: 2007-07-17 Impact factor: 2.602
Authors: Albert M Isaacs; Joshua S Shimony; Diego M Morales; Leandro Castaneyra-Ruiz; Alexis Hartman; Madison Cook; Christopher D Smyser; Jennifer Strahle; Matthew D Smyth; Yan Yan; James P McAllister; Robert C McKinstry; David D Limbrick Journal: J Neurosurg Pediatr Date: 2019-07-19 Impact factor: 2.375
Authors: S M Toescu; P W Hales; J Cooper; E W Dyson; K Mankad; J D Clayden; K Aquilina; C A Clark Journal: AJNR Am J Neuroradiol Date: 2022-09-22 Impact factor: 4.966
Authors: Anders Wallin; Gustavo C Román; Margaret Esiri; Petronella Kettunen; Johan Svensson; George P Paraskevas; Elisabeth Kapaki Journal: J Alzheimers Dis Date: 2018 Impact factor: 4.472